NCT05851508View on ClinicalTrials.gov

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

May 1, 2026

Study Completion Date

February 1, 2027

Conditions
Meniere Disease
Interventions
DRUG

Methylprednisolon

Intratympanal injection with Methylprednisolon 62.5 mg/ ml

DRUG

Placebo

Intratympanal injection with saline, natriumchloride 0.9%

Trial Locations (1)

2300RC

RECRUITING

Leiden University Medical Centre, Leiden

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Gelre Hospitals

OTHER

collaborator

Maasstad Hospital

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Medisch Spectrum Twente

OTHER

collaborator

HagaZiekenhuis

OTHER

lead

Leiden University Medical Center

OTHER